Akb-6548-Ci-0014
ClinicalTrials.gov NCT02648347
Research payments
$2,113,699
Through program year 2021, $2,113,699 in research payments was reported against Akb-6548-Ci-0014, across 1,056 payments, paid by Akebia Therapeutics Inc.
- Paid by
- Akebia Therapeutics Inc
- ClinicalTrials.gov
- NCT02648347
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $2,113,699 | 1,056 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kirti Shah Lawrenceville, GA Named on 135 payments
- Manuel Montero New Bern, NC Named on 59 payments
- Aurelio Torres Consuegra Pembroke Pines, FL Named on 57 payments
- David Scott Rosedale, NY Named on 38 payments
- Pablo Pergola San Antonio, TX Named on 32 payments
- Deborah Price Jacksonville, FL Named on 32 payments
- Jorge Posada Coral Gables, FL Named on 28 payments
- Gerardo Varallo Voorhees, NJ Named on 27 payments
- Arnold Silva Meridian, ID Named on 25 payments
- Douglas Shemin Providence, RI Named on 24 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.